Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2021 Sep 6;114(2):373–382. doi: 10.1016/j.athoracsur.2021.08.007

Table 1:

Survey respondent characteristics and current donor management practices

Survey Question Responses
Responses
  Respondents (number of individuals) 40
  OPOs (number of OPOs represented) 30

Years at organization (%)
  <5 4 (10.0)
  5-9 14 (35.0)
  ≥10 22 (55.0)

Estimated number of brain dead donors (%)
  0-100 9 (23.7)
  101-200 19 (50.0)
  201-300 4 (10.5)
  >300 6 (15.8)

Estimated lung utilization rate (median, IQR) 30.0 (15.0)

Where are brain dead donors managed? (%)
  Hospitals 27 (71.1)
  Hospitals and/or SDCFs 11 (29.0)

Who manages brain dead donors? (%)
  Coordinators 35 (92.1)
  Other 3 (7.9)

Average duration of lung donor management (%)
  24-48 hours 26 (68.4)
  49-72 hours 12 (31.6)

Mode of ventilation (%)
  Pressure Regulated Volume Control (PRVC) 15 (40.5)
  Airway Pressure Release Ventilation (APRV) 4 (10.8)
  Assist Control Ventilation (ACV) 6 (16.2)
  Combination of modes or other 12 (32.4)

Donor management (%)
  Perform CXR w/in 3 hrs of offer, repeating every 12 hrs 26 (74.3)
  Perform early bronchoscopy on all donors 35 (94.6)
  Perform intrapulmonary percussive ventilation 10 (27.8)
  Perform ABG every 4 hours or with ventilatory changes 36 (97.3)
  Perform lung recruitment for PaO2/FiO2 < 300 36 (97.3)

Antibiotic management (%)
  Administered routinely 33 (89.2)
  Administered as needed 4 (10.8)
  Not administered 0 (0.0)

Bronchodilator management (%)
  Administered routinely 18 (48.7)
  Administered as needed 17 (46.0)
  Not administered 2 (5.4)

ABG=arterial blood gas, CXR=chest x-ray, FiO2= fraction of inspired oxygen, PaO2=partial pressure of oxygen, SDCF=specialized donor care facility